Founder & CEO, PanTher Therapeutics
Laura Indolfi is the Founder & CEO of PanTher Therapeutics, a spin-out of MIT and MGH that provides superior drug delivery technologies for revolutionizing the treatment of locally advanced solid tumors. Her scientific expertise covers a broad range of therapeutic areas (cardio, cancer, regenerative medicine) and approaches (drug delivery, cell therapy, implanted devices). Together with her strong technical background, Laura has hands-on business and managerial know-how developed during her biomedical business training at Sloan and Harvard Business schools, combining the science and business knowledges to drive the company’s vision. Prior to PanTher, she was a research associate at Harvard-MIT IMES, and served as entrepreneur-in-residence at MGH Cancer Center. She is a TED Fellow, one of 21 people chosen annually by the TED organization who are considered to be the most disruptive and transformative change-makers in the world. In 2017, she attended the prestigious conference “Fortune: Most Powerful Women – Next Gen”, an invite-only summit hosted by Fortune gathering a stellar group of game-changing executives, entrepreneurs and innovators. Laura is also one of the 5 women selected by Massachusetts Life Science Center and Takeda for their inaugural class in 2018 of MassNextGen program, honoring exceptional leaders in the biotech industry.